How Do We Choose Our Identity? A Revealed Preference Approach Using Food Consumption

Multiple vaccines: how do we choose?

BACKGROUND As preventive medicine is a cornerstone of managed care, most health plans have traditionally featured automatic vaccine coverage routed through the medical benefit. However, with the advent of emerging vaccines, managed care stakeholders must revise decision-making processes and choose among multiple products targeting the same disease. OBJECTIVE To review the motivating forces be...

How do we choose a therapeutic regimen in cystic fibrosis?

P2Y12 inhibitors in acute coronary syndromes: how do we choose the best drug for our patients?

Thrombosis and Haemostasis 108.2/2012 The development of oral inhibitors of the platelet P2Y12 receptor has improved outcomes in patients with acute coronary syndromes (ACS) and in patients with coronary artery disease undergoing percutaneous coronary intervention (PCI) with stenting. The first thienopyridine drug, ticlopidine, proved to be effective after coronary stenting, but because of many...

How costly is hospital quality? A revealed-preference approach.

We analyze the cost of quality improvement in hospitals, dealing with two challenges. Hospital quality is multidimensional and hard to measure, while unobserved productivity may influence quality supply. We infer the quality of hospitals in Los Angeles from patient choices. We then incorporate ‘revealed quality’ into a cost function, instrumenting with hospital demand. We find that revealed qua...

Do we really know what pesticides are in our food?